EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual‐Functional Hafnium Oxide Nanoplatform Combining High‐Z Radiosensitization With Bcl‐2 Gene Silencing for Enhanced Cancer Radiotherapy

Seungyong Shin iD, Ga-Hyun Bae iD, Jun-Hyeok Han iD, Ha Eun Shin iD, Joo Dong Park iD, Seunghyo Ko iD, Eun-Young Koh iD, Jieun Han iD, Su Chul Han iD, Jason Joon Bock Lee iD, Dong-Hyun Kim iD, Heerim Nam iD und 1 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202404819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Seungyong Shin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University (SKKU), Seobu-ro 2066, Suwon, Gyeonggi,…. Hauptthemen laut MEDLINE: Radiation-Sensitizing Agents, Proto-Oncogene Proteins c-bcl-2, Nanoparticles, Hafnium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of radiotherapy is often limited by insufficient radiosensitization and tumor radioresistance. This study reports a dual‐functional hafnium oxide nanoplatform that combines high‐Z radiosensitization with Bcl‐2 gene silencing for enhanced cancer radiotherapy. The nanoplatform is developed by surface modification of hafnium oxide nanoparticles with polyethyleneimine, enabling efficient siRNA delivery while maintaining inherent high‐Z radiosensitizing properties. Comprehensive physicochemical characterization confirmed the successful surface modification and stable siRNA complexation. Upon radiation exposure, the nanoplatform enhanced reactive oxygen species generation and DNA damage while simultaneously delivering Bcl‐2 siRNA to suppress radioresistance mechanisms. In vitro studies revealed significant enhancement of radiation‐induced cell death through synergistic effects of high‐Z radiosensitization and Bcl‐2 silencing, evidenced by increased γ‐H2AX expression and apoptotic cell population. In a murine colon cancer model, the nanoplatform achieved remarkable tumor growth inhibition (80%) when combined with radiotherapy while exhibiting favorable biocompatibility in major organs. Mechanistic studies confirmed effective Bcl‐2 downregulation and enhanced DNA damage in tumor tissues, validating this dual‐functional therapeutic approach. This study presents a promising strategy for improving radiotherapy outcomes through the simultaneous enhancement of radiosensitization and suppression of radioresistance, potentially advancing the field of cancer radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation-Sensitizing AgentsProto-Oncogene Proteins c-bcl-2NanoparticlesHafniumGene SilencingOxidesColonic NeoplasmsAnimalsMiceHumansRNA, Small InterferingCell Line, TumorDNA DamageApoptosisReactive Oxygen SpeciesMice, Inbred BALB C

Stichwörter der Autor:innen

Bcl‐2 silencingcancer radiotherapyhafnium oxide nanoplatformradiosensitizationsiRNA delivery

Substanzen

Radiation-Sensitizing AgentsProto-Oncogene Proteins c-bcl-2RNA, Small InterferingHafniumOxidesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University (SKKU), Seobu-ro 2066, Suwon, Gyeonggi, 16419, Republic of Korea.
  • Department of MetaBioHealth, Institute for Cross-disciplinary Studies (ICS), SKKU, Seobu-ro 2066, Suwon, Gyeonggi, 16419, Republic of Korea.
  • Department of Radiation Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Saemunan-ro 29, Seoul, 03181, Republic of Korea.
  • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, 60611, USA.
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, 60611, USA.
  • Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, Evanston, IL, 60208, USA.

ORCID-Profile: Seungyong Shin, Ga-Hyun Bae, Jun-Hyeok Han, Ha Eun Shin, Joo Dong Park, Seunghyo Ko, Eun-Young Koh, Jieun Han, Su Chul Han, Jason Joon Bock Lee, Dong-Hyun Kim, Heerim Nam, Wooram Park

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Shin, S., Bae, G. H., Han, J. H., Shin, H. E., Park, J. D., Ko, S., Koh, E. Y., Han, J., Han, S. C., Lee, J. J. B., Kim, D. H., Nam, H., & Park, W. (2025). Dual‐Functional Hafnium Oxide Nanoplatform Combining High‐Z Radiosensitization With Bcl‐2 Gene Silencing for Enhanced Cancer Radiotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404819

Vancouver

Shin S, Bae GH, Han JH, Shin HE, Park JD, Ko S, et al. Dual‐Functional Hafnium Oxide Nanoplatform Combining High‐Z Radiosensitization With Bcl‐2 Gene Silencing for Enhanced Cancer Radiotherapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404819

BibTeX
@article{Shin2025,
  author = {Shin, Seungyong and Bae, Ga-Hyun and Han, Jun-Hyeok and Shin, Ha Eun and Park, Joo Dong and Ko, Seunghyo and Koh, Eun-Young and Han, Jieun and Han, Su Chul and Lee, Jason Joon Bock and Kim, Dong-Hyun and Nam, Heerim and Park, Wooram},
  title = {Dual‐Functional Hafnium Oxide Nanoplatform Combining High‐Z Radiosensitization With Bcl‐2 Gene Silencing for Enhanced Cancer Radiotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202404819}
}
Kostenlos starten →